320 related articles for article (PubMed ID: 19487308)
21. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains.
Jafferali S; Dumont Y; Sotty F; Robitaille Y; Quirion R; Kar S
Synapse; 2000 Dec; 38(4):450-9. PubMed ID: 11044892
[TBL] [Abstract][Full Text] [Related]
23. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
Chauhan NB; Siegel GJ
J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811
[TBL] [Abstract][Full Text] [Related]
24. IGF-1 promotes beta-amyloid production by a secretase-independent mechanism.
Araki W; Kume H; Oda A; Tamaoka A; Kametani F
Biochem Biophys Res Commun; 2009 Feb; 380(1):111-4. PubMed ID: 19167357
[TBL] [Abstract][Full Text] [Related]
25. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
Zemva J; Schubert M
Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
[TBL] [Abstract][Full Text] [Related]
26. S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse.
Han K; Jia N; Zhong Y; Shang X
J Cell Biochem; 2018 Apr; 119(4):3111-3117. PubMed ID: 29058763
[TBL] [Abstract][Full Text] [Related]
27. The Alzheimer's disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons.
George C; Gontier G; Lacube P; François JC; Holzenberger M; Aïd S
Brain; 2017 Jul; 140(7):2012-2027. PubMed ID: 28595357
[TBL] [Abstract][Full Text] [Related]
28. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways.
Stein TD; Johnson JA
J Neurosci; 2002 Sep; 22(17):7380-8. PubMed ID: 12196559
[TBL] [Abstract][Full Text] [Related]
29. Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance.
Herrero-Labrador R; Trueba-Saiz A; Martinez-Rachadell L; Fernandez de Sevilla ME; Zegarra-Valdivia JA; Pignatelli J; Diaz-Pacheco S; Fernandez AM; Torres Aleman I
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352990
[TBL] [Abstract][Full Text] [Related]
30. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
[TBL] [Abstract][Full Text] [Related]
31. Reduction in Aβ-induced cell death in the hippocampus of 17β-estradiol-treated female rats is associated with an increase in IGF-I signaling and somatostatinergic tone.
Perianes-Cachero A; Canelles S; Aguado-Llera D; Frago LM; Toledo-Lobo MV; Carrera I; Cacabelos R; Chowen JA; Argente J; Arilla-Ferreiro E; Barrios V
J Neurochem; 2015 Dec; 135(6):1257-71. PubMed ID: 26442993
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner.
Niikura T; Hashimoto Y; Okamoto T; Abe Y; Yasukawa T; Kawasumi M; Hiraki T; Kita Y; Terashita K; Kouyama K; Nishimoto I
J Neurosci; 2001 Mar; 21(6):1902-10. PubMed ID: 11245675
[TBL] [Abstract][Full Text] [Related]
33. Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.
Killick R; Scales G; Leroy K; Causevic M; Hooper C; Irvine EE; Choudhury AI; Drinkwater L; Kerr F; Al-Qassab H; Stephenson J; Yilmaz Z; Giese KP; Brion JP; Withers DJ; Lovestone S
Biochem Biophys Res Commun; 2009 Aug; 386(1):257-62. PubMed ID: 19523444
[TBL] [Abstract][Full Text] [Related]
34. [Study of the correlation about IGF-I receptor and β-amyloid in Alzheimer's disease].
Liu X; Zhang YN; Jiang LH; Teng ZY
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(15):1062-5. PubMed ID: 22781651
[TBL] [Abstract][Full Text] [Related]
35. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.
Higaki S; Muramatsu M; Matsuda A; Matsumoto K; Satoh JI; Michikawa M; Niida S
PLoS One; 2018; 13(5):e0196929. PubMed ID: 29738527
[TBL] [Abstract][Full Text] [Related]
36. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
37. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
[TBL] [Abstract][Full Text] [Related]
38. Down-regulating insulin-like growth factor-1 receptor reduces amyloid-β deposition in mice cortex induced by chronic sleep restriction.
Wang M; Zhao H; Zhang Z; Zhao Z; Wu H
Neurosci Lett; 2023 Jun; 808():137189. PubMed ID: 36921668
[TBL] [Abstract][Full Text] [Related]
39. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.
Cohen E; Paulsson JF; Blinder P; Burstyn-Cohen T; Du D; Estepa G; Adame A; Pham HM; Holzenberger M; Kelly JW; Masliah E; Dillin A
Cell; 2009 Dec; 139(6):1157-69. PubMed ID: 20005808
[TBL] [Abstract][Full Text] [Related]
40. The impairment of insulin signaling in Alzheimer's disease.
Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
